Join BJS Academy
BJS Academy>Randomized clinical ...>Short term outcomes ...
Normal View Dyslexic View

Short-term outcomes following laparoscopic vs open pancreaticoduodenectomy in patients with pancreatic ductal adenocarcinoma. A randomized clinical trial.

22 February 2024
Randomized clinical trials HPB
Wang M, Pan S, Qin T, Xu X, Huang X, Liu J et al.

JAMA Surg 2023; 158: 1245-1253. 

Among 412  eligible patients, 200 were randomized. Laparoscopic surgery took longer (330 versus 297 min, P<0.001), and resulted in lower median blood loss (145 versus 200ml, P=0.02), but overall complication rates and hospital stay were similar. Only two patients died within 90 days, both in the laparoscopic group.

Comment: Differences in outcomes surprisingly small.

BJS Foundation Limited
BJS Academy
0000-0000
BJS Foundation Limited
London, UK
rct033
Randomized clinical trials
Randomized clinical trials
HPB
Short-term outcomes following laparoscopic vs open pancreaticoduodenectomy in patients with pancreatic ductal adenocarcinoma. A randomized clinical trial.
Wang M, Pan S, Qin T, Xu X, Huang X, Liu J et al.
22022024
JAMA Surg 2023; 158: 1245-1253. 
Among 412  eligible patients, 200 were randomized. Laparoscopic surgery took longer (330 versus 297 min, P<0.001), and resulted in lower median blood loss (145 versus 200ml, P=0.02), but overall complication rates and hospital stay were similar. Only two patients died within 90 days, both in the laparoscopic group.
Comment: Differences in outcomes surprisingly small.
Published on: 22 February 2024
Article ID: rct033

Related articles

Temporary portocaval shunt provides superior intraoperative hemodynamics and reduces blood loss and duration of surgery in live donor liver transplantation. A randomized controlled trial.

Kumar M, Patil NS, Mohapatra N, Sindwani G, Dhingra U, Yadav A et al.
Ann Surg 2024; 279: 932-944.

16 August 2024

Upfront endoscopic necrosectomy or step-up endoscopic approach for infected necrotising pancreatitis (DESTIN): a single-blinded, multicentre, randomised trial.

Bang JY, Lakhtakia S, Thakkar S, Buxbaum JL, Waxman I, Sutton B et al, on behalf of the United States Pancreatic Disease Study Group.

16 August 2024

Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial.

Labori KJ, Bratlie SO, Andersson B, Angelsen J-H, Biorserud C, Bjornsson B et al, for the Nordic Pancreatic Cancer Trial-1 study group.

30 August 2024
Home
  • Normal view
  • Dyslexic view
Info
Copied!